4-102869096-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6BP7
The NM_001008388.5(CISD2):c.12G>A(p.Glu4Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000173 in 1,611,418 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00087 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000099 ( 0 hom. )
Consequence
CISD2
NM_001008388.5 synonymous
NM_001008388.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.70
Genes affected
CISD2 (HGNC:24212): (CDGSH iron sulfur domain 2) The protein encoded by this gene is a zinc finger protein that localizes to the endoplasmic reticulum. The encoded protein binds an iron/sulfur cluster and may be involved in calcium homeostasis. Defects in this gene are a cause of Wolfram syndrome 2. [provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.27).
BP6
Variant 4-102869096-G-A is Benign according to our data. Variant chr4-102869096-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 288522.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}. Variant chr4-102869096-G-A is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=1.7 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CISD2 | NM_001008388.5 | c.12G>A | p.Glu4Glu | synonymous_variant | 1/3 | ENST00000273986.10 | NP_001008389.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CISD2 | ENST00000273986.10 | c.12G>A | p.Glu4Glu | synonymous_variant | 1/3 | 1 | NM_001008388.5 | ENSP00000273986.4 | ||
CISD2 | ENST00000574446.1 | n.12G>A | non_coding_transcript_exon_variant | 1/4 | 5 | ENSP00000458976.1 | ||||
CISD2 | ENST00000646632.1 | n.12G>A | non_coding_transcript_exon_variant | 1/4 | ENSP00000494257.1 |
Frequencies
GnomAD3 genomes AF: 0.000880 AC: 134AN: 152236Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
134
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000180 AC: 44AN: 244294Hom.: 0 AF XY: 0.000106 AC XY: 14AN XY: 132470
GnomAD3 exomes
AF:
AC:
44
AN:
244294
Hom.:
AF XY:
AC XY:
14
AN XY:
132470
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000994 AC: 145AN: 1459064Hom.: 0 Cov.: 33 AF XY: 0.0000827 AC XY: 60AN XY: 725518
GnomAD4 exome
AF:
AC:
145
AN:
1459064
Hom.:
Cov.:
33
AF XY:
AC XY:
60
AN XY:
725518
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000873 AC: 133AN: 152354Hom.: 1 Cov.: 32 AF XY: 0.000752 AC XY: 56AN XY: 74504
GnomAD4 genome
AF:
AC:
133
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
56
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 23, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
CISD2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 26, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at